Clinical Trial: Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of DW5421A/DW5421B Compared to Monotherapy of DW5421A

U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07444762) titled 'Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of DW5421A/DW5421B Compared to Monotherapy of DW5421A' on Feb. 25.

Brief Summary: This is a multicenter, randomized, double-blind, active-controlled, parallel, phase III clinical trial to evaluate the efficacy and safety of combination therapy of DW5421A/DW5421B versus monotherapy of DW5421A in patients with primary hypercholesterolemia or mixed dyslipidemia.

Study Start Date: April 21, 2025

Study Type: INTERVENTIONAL

Condition: Primary Hypercholesterolemia Mixed Dyslipidemia

Intervention: DRUG: Combination Therapy of DW5421A/DW5421B

IP is administered ...